Connect
MJA
MJA

Randomised clinical trials in perinatal health care: a cost-effective investment

Clarabelle T Pham, Jonathan D Karnon, Philippa F Middleton, Frank H Bloomfield, Katie M Groom, Caroline A Crowther and Ben W Mol
Med J Aust 2017; 207 (7): 289-293. || doi: 10.5694/mja16.01178

Abstract

Objective: To compare the health and economic impacts of implementing efficacious treatment interventions with maintaining standard practice in maternal and perinatal health care.

Design and setting: We identified randomised clinical trials (RCTs) in the Perinatal Society of Australia and New Zealand trials database that commenced recruitment during 2008 and had completed recruitment by 2015. Data from clinical trial registries and publications were collated to calculate the potential cost savings achievable by implementing efficacious treatment interventions.

Main outcome measure: Projected net cost savings over 5 years.

Results: Twenty-three eligible RCTs covering a range of behavioural and clinical interventions were identified, of which six reported interventions superior to standard practice (four trials) or placebo (two). The outcomes (but not the costs) of 17 trials were excluded from analysis (no difference between intervention and comparator groups in seven trials, recruitment problems in six, findings not yet published in four). The total funding amount for the 23 trials was $20.3 million; the potential cost savings over 5 years if the findings of the six trials reporting superior interventions were implemented was estimated to be $26.3 million if 10% of the eligible populations received the effective interventions, and $262.8 million with 100% implementation.

Conclusions: Our retrospective analysis highlights the value of research in perinatal care and the importance of implementing positive findings for realising its value. Future trials in maternal and perinatal health care may provide significant returns on investment by informing clinical practice, improving patient outcomes and reducing health care costs.

Please login with your free MJA account to view this article in full

  • Clarabelle T Pham1
  • Jonathan D Karnon1
  • Philippa F Middleton2
  • Frank H Bloomfield3
  • Katie M Groom4
  • Caroline A Crowther3
  • Ben W Mol4

  • 1 University of Adelaide, Adelaide, SA
  • 2 Robinson Research Institute, University of Adelaide, Adelaide, SA
  • 3 Liggins Institute, University of Auckland, Auckland, New Zealand
  • 4 University of Auckland, Auckland, New Zealand


Acknowledgements: 

Ben Mol is supported by a National Health and Medical Research Council Practitioner Fellowship (GNT1082548).

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.